What Information Can We Gain from This Test in Cancer Research?
The primary benefit of adapting the Kirby-Bauer test for cancer research is to determine the sensitivity of cancer cells to various chemotherapeutic agents. This helps in identifying which drugs are most effective in inhibiting or killing specific cancer cell lines. The size of the zone of inhibition can indicate the potency of the drug, guiding researchers in drug selection and dosage optimization.
